Loading the company…
Loading the company…
㈜심다
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Busan, founded in 2017. Industry: Medical & Precision Devices. Revenue for 2025 was ₩4.2bn. It has 19 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2020-05-07 · newest first
본 발명은 내부에 중공이 형성되는 지대주와, 하부는 상기 지대주 하부를 관통하여 상기 지대주의 외부에 위치하고, 상부는 상기 지대주 내부의 중공에 위치하여 상기 지대주를 인공치아에 고정하는 하부 스크류 및, 상기 지대주 내부에 형성된 중공을 채우기 위해, 몸체 전체가 상기 지대주 내부의 중공에 삽입되고, 하부는 상기 하부 스크류 상부에 결합하는 상부 스크류를 포함하는 이중 스크류를 구비하는 임플란트에 관한 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 3.0 | 4.2 |
| Cost of sales | 2.1 | 2.8 |
| Gross profit (loss) | 0.9 | 1.4 |
| Selling, general and administrative expenses | 0.7 | 1.1 |
| Operating income (loss) | 0.2 | 0.3 |
| Non-operating income | 0.0 | 0.6 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.0 | 0.6 |
| Non-operating expenses | 0.5 | 0.6 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.5 | 0.6 |
| Other | — | 0.0 |
| Profit (loss) before tax | (0.3) | 0.4 |
| Net income (loss) | (0.3) | 0.4 |
Revenue ₩4.2bn, up 42.3% YoY.
Operating margin 8.0% (prior 7.3%).
Net income ₩0.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-08